|
| Balwinder Singh | Mayo Clinic |
| Rebecca Strawbridge | Institute of Psychiatry, King's College London |
| Katherine E Burdick | Harvard Medical School, Brigham and Women's Hospital |
| Sarah H Sperry | University of Michigan ann arbor |
| Giovanna Fico | Institute of Neuroscience, Hospital Clinic, University of Barcelona |
| Eduard Vieta | Institute of Neuroscience, Hospital Clinic, University of Barcelona |
| Marion Leboyer | INSERM U |
| Marion Leboyer | Departement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Hopitaux Universitaires Henri Mondor, Federation Hospitalo-Universitaire de Medecine de Precision en Psychiatrie (FHU ADAPT) |
| Brandon J Coombes | Mayo Clinic |
| Melvin G McInnis | University of Michigan ann arbor |
| Andrew A Nierenberg | Dauten Family Center for Bipolar Treatment Innovation, Harvard Medical School, Massachusetts General Hospital |
| Allan H Young | Institute of Psychiatry, King's College London |
| Allan H Young | Institute of Psychiatry, King's College London |
| Lakshmi N Yatham | University of British Columbia |
| Janice M Fullerton | |
| Janice M Fullerton | University of New South Wales |
| Philip B Mitchell | University of New South Wales |
| Ole A Andreassen | University of Oslo and Oslo University Hospital |
| Peter P Zandi | Johns Hopkins School of Medicine |
| Joanna M Biernacka | Mayo Clinic |
| Joanna M Biernacka | Groupe Hospitalo-universitaire AP-HP Nord, INSERM UMRS 4, Universite de Paris |
| Mark A Frye | Mayo Clinic |